Chinese Academy of Medical Sciences COVID-19 vaccine, or IMBCAMS COVID-19 vaccine, traded as Covidful ( zh, s=科维福, p=Kēwéifú), is a

COVID-19 vaccine A COVID19 vaccine is a vaccine intended to provide acquired immunity against severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2), the virus that causes coronavirus disease 2019 ( COVID19). Prior to the COVID19 pandemic, an e ...

developed by .

Clinical trials

In May 2020, Covidful started phase I/II clinical trial with 942 participants in China. In January 2021, Covidful started phase III clinical trials with 34,020 from Brazil and Malaysia.

Authorizations

On 9 June 2021, The vaccine has been approved by the Chinese authorities.

References

External links

Chinese COVID-19 vaccines Inactivated vaccines {{Vaccine-stub